Connor, Clark & Lunn Investment Management (CC&L)’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-123,822	Closed	-$318K	–	1467
2022 Q3	$318K	Buy	123,822 +107,141	+642%	+$341K	﹤0.01%	908
2022 Q2	$40K	Buy	+16,681	New	+$43.8K	﹤0.01%	1013
2022 Q1	–	Sell	-130,622	Closed	-$1.68M	–	1248
2021 Q4	$1.68M	Buy	+130,622	New	+$1.45M	0.01%	574
2021 Q3	–	Sell	-53,222	Closed	-$486K	–	1249
2021 Q2	$486K	Buy	53,222 +4,270	+9%	+$39.5K	﹤0.01%	796
2021 Q1	$462K	Buy	+48,952	New	+$674K	﹤0.01%	800

Other funds holding GRTS

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s GRTS Position: Q4 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2022, closing a stake of 123,822 shares — an estimated $318K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in GRTS in Q1 2021 and held it in 5 quarters. The position peaked at $1.68M in Q4 2021. 91 funds tracked by Wall St. Rank hold GRTS as of Q4 2022.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 123,822 Gritstone bio, Inc. Common Stock shares in Q4 2022, an estimated $318K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Gritstone bio, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Gritstone bio, Inc. Common Stock position peaked at $1.68M in Q4 2021.
91 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2022, filed 10 Feb 2023.